In a study by Weulersse et al., defective activation of LFA-1 into its high-affinity conformation was identified as a key factor impairing CD8+ T cell responses across several human malignancies, including multiple myeloma, lung adenocarcinoma, breast carcinoma, and ovarian carcinoma (82). Here, ITGB2 is linked to plasma cell myeloma.